List of vTv Therapeutics patents

Patents where

Current Assignee

Name

vTv Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10004782 Glucokinase activator compositions for the treatment of diabetes	Patent 10004782 was granted and assigned to vTv Therapeutics on June, 2018 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10004782	June 26, 2018
‌ US Patent 9717710 Treatment of mild and moderate Alzheimer's disease	Patent 9717710 was granted and assigned to vTv Therapeutics on August, 2017 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9717710	August 1, 2017
‌ US Patent 11649230 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof	Patent 11649230 was granted and assigned to vTv Therapeutics on May, 2023 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	11649230	May 16, 2023
‌ US Patent 10287284 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof	Patent 10287284 was granted and assigned to vTv Therapeutics on May, 2019 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10287284	May 14, 2019
‌ US Patent 10889580 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof	Patent 10889580 was granted and assigned to vTv Therapeutics on January, 2021 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10889580	January 12, 2021
‌ US Patent 10363244 Compositions comprising metformin and a glucokinase activator	Patent 10363244 was granted and assigned to vTv Therapeutics on July, 2019 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10363244	July 30, 2019
‌ US Patent 9359313 Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator	Patent 9359313 was granted and assigned to vTv Therapeutics on June, 2016 by the United States Patent and Trademark Office.		vTv Therapeutics	United States Patent and Trademark Office	9359313	June 7, 2016
‌ US Patent 9447468 Compounds that modulate oxidative stress	Patent 9447468 was granted and assigned to vTv Therapeutics on September, 2016 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9447468	September 20, 2016
‌ US Patent 9707239 Compounds that modulate oxidative stress	Patent 9707239 was granted and assigned to vTv Therapeutics on July, 2017 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9707239	July 18, 2017
‌ US Patent 10952993 Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs	Patent 10952993 was granted and assigned to vTv Therapeutics on March, 2021 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10952993	March 23, 2021
‌ US Patent 10064846 Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator	Patent 10064846 was granted and assigned to vTv Therapeutics on September, 2018 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10064846	September 4, 2018
‌ US Patent 9855251 Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator	Patent 9855251 was granted and assigned to vTv Therapeutics on January, 2018 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9855251	January 2, 2018
‌ US Patent 9663481 Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists	Patent 9663481 was granted and assigned to vTv Therapeutics on May, 2017 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9663481	May 30, 2017
‌ US Patent 9855274 Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists	Patent 9855274 was granted and assigned to vTv Therapeutics on January, 2018 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9855274	January 2, 2018
‌ US Patent 11420929 Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists	Patent 11420929 was granted and assigned to vTv Therapeutics on August, 2022 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	11420929	August 23, 2022
‌ US Patent 10456406 Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb	Patent 10456406 was granted and assigned to vTv Therapeutics on October, 2019 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10456406	October 29, 2019
‌ US Patent 9968613 Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb	Patent 9968613 was granted and assigned to vTv Therapeutics on May, 2018 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	9968613	May 15, 2018
‌ US Patent 11130753 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof	Patent 11130753 was granted and assigned to vTv Therapeutics on September, 2021 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	11130753	September 28, 2021
‌ US Patent 10570126 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof	Patent 10570126 was granted and assigned to vTv Therapeutics on February, 2020 by the United States Patent and Trademark Office.		vTv Therapeutics	United States Patent and Trademark Office	10570126	February 25, 2020
‌ US Patent 10030011 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof	Patent 10030011 was granted and assigned to vTv Therapeutics on July, 2018 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10030011	July 24, 2018
‌ US Patent 10947180 Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists	Patent 10947180 was granted and assigned to vTv Therapeutics on March, 2021 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10947180	March 16, 2021
‌ US Patent 11524942 Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine	Patent 11524942 was granted and assigned to vTv Therapeutics on December, 2022 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	11524942	December 13, 2022
‌ US Patent 10898475 Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof	Patent 10898475 was granted and assigned to vTv Therapeutics on January, 2021 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10898475	January 26, 2021
‌ US Patent 10172840 Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof	Patent 10172840 was granted and assigned to vTv Therapeutics on January, 2019 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10172840	January 8, 2019
‌ US Patent 10463652 Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof	Patent 10463652 was granted and assigned to vTv Therapeutics on November, 2019 by the United States Patent and Trademark Office.	vTv Therapeutics	vTv Therapeutics	United States Patent and Trademark Office	10463652	November 5, 2019

Results per page:

50 results

0 selected

50 results

0 selected